News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
135,514 Results
Type
Article (4534)
Company Profile (88)
Press Release (130892)
Multimedia
Podcasts (3)
Webinars (6)
Section
Business (43332)
Career Advice (211)
Deals (6348)
Drug Delivery (14)
Drug Development (20148)
Employer Resources (18)
FDA (1578)
Job Trends (2857)
News (70068)
Policy (3797)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (4)
2025 Lone Star Bio Digital (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (300)
Adcomms (1)
Allergies (16)
Alliances (11607)
ALS (31)
Alzheimer's disease (406)
Antibody-drug conjugate (ADC) (30)
Approvals (1593)
Artificial intelligence (51)
Autoimmune disease (15)
Automation (4)
Bankruptcy (38)
Best Places to Work (2316)
BIOSECURE Act (14)
Biosimilars (9)
Biotechnology (85)
Bladder cancer (23)
Brain cancer (6)
Breast cancer (73)
Cancer (592)
Cardiovascular disease (18)
Career advice (200)
Career pathing (5)
CAR-T (60)
Cell therapy (174)
Cervical cancer (6)
Clinical research (16685)
Collaboration (266)
Compensation (117)
Complete response letters (2)
COVID-19 (450)
CRISPR (10)
C-suite (105)
Cystic fibrosis (37)
Data (677)
Depression (8)
Diabetes (57)
Diagnostics (703)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (44)
Drug pricing (5)
Drug shortages (2)
Duchenne muscular dystrophy (27)
Earnings (13578)
Editorial (4)
Employer resources (18)
Events (25379)
Executive appointments (277)
FDA (1834)
Featured Employer (13)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (238)
Gene editing (24)
Generative AI (4)
Gene therapy (86)
GLP-1 (129)
Government (358)
Guidances (11)
Healthcare (1617)
Huntington's disease (7)
IgA nephropathy (8)
Immunology and inflammation (25)
Indications (11)
Infectious disease (480)
Inflammatory bowel disease (55)
Inflation Reduction Act (1)
Influenza (17)
Intellectual property (36)
Interviews (18)
IPO (3084)
IRA (4)
Job creations (677)
Job search strategy (185)
Kidney cancer (2)
Labor market (9)
Layoffs (43)
Legal (642)
Liver cancer (15)
Lung cancer (44)
Lymphoma (58)
Management (4)
Manufacturing (91)
MASH (11)
Medical device (421)
Medtech (421)
Mergers & acquisitions (3463)
Metabolic disorders (143)
Multiple sclerosis (27)
NASH (2)
Neurodegenerative disease (20)
Neuropsychiatric disorders (4)
Neuroscience (553)
NextGen: Class of 2025 (878)
Non-profit (283)
Northern California (886)
Now hiring (6)
Obesity (78)
Opinion (42)
Ovarian cancer (29)
Pain (24)
Pancreatic cancer (24)
Parkinson's disease (50)
Partnered (4)
Patents (57)
Patient recruitment (30)
Peanut (12)
People (16586)
Pharmaceutical (8)
Phase I (7506)
Phase II (7509)
Phase III (3653)
Pipeline (355)
Policy (26)
Postmarket research (223)
Preclinical (2514)
Press Release (51)
Prostate cancer (21)
Psychedelics (2)
Radiopharmaceuticals (47)
Rare diseases (82)
Real estate (1452)
Recruiting (10)
Regulatory (3119)
Reports (13)
Research institute (309)
Resumes & cover letters (21)
RNA editing (1)
RSV (4)
Schizophrenia (16)
Series A (44)
Series B (30)
Service/supplier (2)
Sickle cell disease (11)
Southern California (803)
Special edition (1)
Spinal muscular atrophy (39)
Sponsored (4)
Startups (994)
State (1)
Stomach cancer (2)
Supply chain (18)
Tariffs (7)
The Weekly (3)
United States (6663)
Vaccines (78)
Venture capitalists (7)
Weight loss (26)
Women's health (4)
Worklife (2)
Date
Today (58)
Last 7 days (251)
Last 30 days (771)
Last 365 days (9310)
2025 (2979)
2024 (9651)
2023 (10499)
2022 (12730)
2021 (13384)
2020 (10371)
2019 (7022)
2018 (5519)
2017 (6337)
2016 (5842)
2015 (6710)
2014 (5089)
2013 (4152)
2012 (4519)
2011 (4989)
2010 (4609)
Location
Africa (139)
Alabama (32)
Alaska (1)
Arizona (27)
Arkansas (2)
Asia (8814)
Australia (2050)
California (2033)
Canada (583)
China (120)
Colorado (34)
Connecticut (74)
Delaware (29)
Europe (19302)
Florida (191)
Georgia (36)
Idaho (10)
Illinois (131)
India (4)
Indiana (105)
Iowa (1)
Japan (34)
Kansas (12)
Kentucky (2)
Louisiana (1)
Maine (2)
Maryland (224)
Massachusetts (1496)
Michigan (68)
Minnesota (96)
Missouri (8)
Montana (8)
Nebraska (2)
Nevada (4)
New Hampshire (5)
New Jersey (443)
New Mexico (6)
New York (482)
North Carolina (277)
North Dakota (4)
Northern California (886)
Ohio (42)
Oklahoma (5)
Oregon (6)
Pennsylvania (406)
Puerto Rico (3)
Rhode Island (5)
South America (202)
South Carolina (1)
Southern California (803)
Tennessee (15)
Texas (231)
Utah (21)
Virginia (14)
Washington D.C. (8)
Washington State (347)
Wisconsin (8)
135,514 Results for "ascendance biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AtaCor Medical Enrolls First Patients in its ASCEND EV Clinical Study
March 24, 2025
·
3 min read
Press Releases
Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease
March 4, 2025
·
8 min read
Press Releases
Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director
March 5, 2025
·
3 min read
Press Releases
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
March 11, 2025
·
9 min read
Press Releases
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis
April 9, 2025
·
6 min read
Press Releases
Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025
April 1, 2025
·
7 min read
BioMidwest
ASCEND’s Telepresence Technology, Catalyst LIVE, Transforms Diagnostic Imaging
ASCEND Cardiovascular’s newest technology, Catalyst LIVE, currently implemented at two pioneering hospital sites, has pilots underway since 2022 at Stanford Medicine Children’s Health in California and Cook County Health in Illinois.
January 16, 2024
·
3 min read
Press Releases
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
April 9, 2025
·
2 min read
Press Releases
Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-week Phase IIa Study Protocol to FDA
April 23, 2025
·
5 min read
Press Releases
Satellos Announces Completed Enrollment of all Four Multiple-Ascending Dose Cohorts for the Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers
February 10, 2025
·
6 min read
1 of 13,552
Next
